N/A
Completed N=94
Barrow Nasal Inventory Survey
Source: ClinicalTrials.gov NCT01322945 ↗Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Dec 2013
Primary outcomePrimary: Change in Mean Survey Response From Baseline to 90 Days Post Surgery — 17.3; 13.5 units on a scale — p=0.001
Summary
The purpose of this study is to evaluate patient nasal outcome following endo-nasal surgery. This type of surgery is conducted for pituitary and skull base tumors. There is no published data on trauma to the nose during surgery and how it impacts nasal functioning. The investigators propose to develop a survey and administer it to patients before and after surgery to learn about their perception of nasal functioning.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean Survey Response From Baseline to 90 Days Post Surgery |
17.3; 13.5 | 0.001 sig |
| SECONDARY Test-retest Reliability of the ASK Nasal Inventory |
0.87; 0.95 | — |
Eligibility Criteria
Inclusion Criteria
- Adults with planned endonasal surgery for pituitary tumor or skull base lesion
Exclusion Criteria
- Children
Data sourced from ClinicalTrials.gov (NCT01322945). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.